Registered Number 16194253

REXTON PHARMA LTD

Micro-entity Accounts

31 January 2026

REXTON PHARMA LTD Registered Number 16194253

Micro-entity Balance Sheet as at 31 January 2026

Notes 2026
£
Called up share capital not paid
-
Fixed Assets
767
Current Assets
17,082
Prepayments and accrued income
-
Creditors: amounts falling due within one year
(9,186)
Net current assets (liabilities)
7,896
Total assets less current liabilities
8,663
Creditors: amounts falling due after more than one year
0
Provisions for liabilities
0
Accruals and deferred income
(28)
Total net assets (liabilities)
8,635
Capital and reserves
8,635
  • For the year ending 31 January 2026 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.
  • The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
  • The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
  • The accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

Approved by the Board on 16 May 2026

And signed on their behalf by:
OKEMADU CHRISTIAN UKACHUKWU, Director

REXTON PHARMA LTD Registered Number 16194253

Notes to the Micro-entity Accounts for the period ended 31 January 2026

1Employees
2026
Average number of employees during the period 2

2Accounting Policies

Basis of measurement and preparation of accounts
Significant accounting policies
Statement Of Compliance
These financial statements have been prepared in accordance with FRS 105, The Financial Reporting Standard applicable to the
Micro-entities Regime, and the provisions of the Companies Act 2006 applicable to micro-entities.
Basis Of Preparation
The financial statements have been prepared under the historical cost convention and in accordance with FRS 105, The Financial
Reporting Standard applicable to the Micro-entities Regime.
The financial statements are prepared in Sterling which is the functional currency of the company.